With FDA Clearance, MeMed Aims to Decentralize Bacterial, Viral Infectious Disease Testing
The company received 510(k) clearance to run the test in whole-blood samples, making it more accessible to settings like urgent care facilities.
Stay updated with breaking news from Memed Key. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company received 510(k) clearance to run the test in whole-blood samples, making it more accessible to settings like urgent care facilities.
The partnership enables DiaSorin to distribute the MeMed BV test on the Liaison XL and XS as well as on the MeMed Key point-of-need system.
MeMed BV to be Added to Beckman Coulter's Access Family of Immunoassay Analysers Beckman Coulter Diagnostics and MeMed have joined forces to collaboratively develop and market the well-established MeMed BV® test. Click to read more...
/PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response...
In this case study, find out how data capture and management activities, programming, and medical writing for a clinical study report...